| Original language | English |
|---|---|
| Pages (from-to) | 1788-1790 |
| Number of pages | 3 |
| Journal | Leukemia and Lymphoma |
| Volume | 54 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2013 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia'. Together they form a unique fingerprint.
Cite this
Al-Riyami, A. Z., Hudoba, M., Young, S., & Forrest, D. (2013). Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia. Leukemia and Lymphoma, 54(8), 1788-1790. https://doi.org/10.3109/10428194.2012.749469